|
Volumn 25, Issue 9, 2006, Pages 1087-1091
|
Treatment of murine Lewis lung cancer with recombinant interleukin-12
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
GAMMA INTERFERON;
INTERLEUKIN 12;
RECOMBINANT PROTEIN;
ANIMAL;
ARTICLE;
BLOOD;
C57BL MOUSE;
CANCER TRANSPLANTATION;
CELL PROLIFERATION;
CYTOLOGY;
CYTOTOXIC T LYMPHOCYTE;
FEMALE;
GENETIC TRANSFECTION;
GENETICS;
IMMUNOLOGY;
IMMUNOTHERAPY;
LEWIS CARCINOMA;
METABOLISM;
MOUSE;
NATURAL KILLER CELL;
PATHOLOGY;
PLASMID;
RANDOMIZATION;
SPLEEN;
TUMOR CELL LINE;
ANIMALS;
CANCER VACCINES;
CARCINOMA, LEWIS LUNG;
CELL LINE, TUMOR;
CELL PROLIFERATION;
FEMALE;
IMMUNOTHERAPY;
INTERFERON TYPE II;
INTERLEUKIN-12;
KILLER CELLS, NATURAL;
MICE;
MICE, INBRED C57BL;
NEOPLASM TRANSPLANTATION;
PLASMIDS;
RANDOM ALLOCATION;
RECOMBINANT PROTEINS;
SPLEEN;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSFECTION;
|
EID: 36049049386
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|